Compounds > gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate
Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and 2-cresolphthalexon

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with 2-cresolphthalexon in 1 studies

Compound Research Comparison

Studies
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)		Trials
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)		Recent Studies (post-2010)
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)		Studies
(2-cresolphthalexon)		Trials
(2-cresolphthalexon)		Recent Studies (post-2010) (2-cresolphthalexon)
638312432204

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berthommier, C; Corot, C; Devoldere, L; Diai, A; Idee, JM; Lin, J; Port, M; Raynal, I; Robert, M1

Other Studies

1 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and 2-cresolphthalexon

ArticleYear
Interference of magnetic resonance imaging contrast agents with the serum calcium measurement technique using colorimetric reagents.
    Journal of pharmaceutical and biomedical analysis, 1999, Volume: 21, Issue:5

    Topics: Bromthymol Blue; Calcium; Colorimetry; Contrast Media; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Mass Spectrometry; Organometallic Compounds; Pharmaceutical Solutions; Phenolphthaleins; Spectrophotometry, Ultraviolet; Titrimetry

1999